Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study

Bipolar Disorders

Volumn 19, Issue 3, 2017, Pages 225-234

  Amann, Benedikt L ^a,b,c,d   Radua, Joaquim ^d,e,f,g   Wunsch, Christian ^h   König, Barbara ^h   Simhandl, Christian ^h  

^a Institute of Neuropsychiatry and Addictions INAD   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^e FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^f KAROLINSKA INSTITUTE   (Sweden)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h Department of Dermatology   (Austria)

Author keywords

affective disorders; bipolar disorder; bTSH; comorbidity; relapse; thyroid diseases

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MANIA; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEUROSIS; OBSERVATIONAL STUDY; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SOMATOFORM DISORDER; STRESS; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; TOBACCO DEPENDENCE; AUSTRIA; BIPOLAR DISORDER; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RECURRENT DISEASE; TIME;

ADULT; AUSTRIA; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL DISORDERS; METABOLIC DISEASES; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; THYROID DISEASES; TIME;

EID: 85020422527     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12495     Document Type: Article

References (54)

1. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68:241-251.
2. Rosa AR, Magalhães PVS, Czepielewski L, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75.
3. Hayes JF, Miles J, Walters K, King M, Osborn DPJ. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 2015;131:417-425.
4. Radua J, Grunze H, Amann BL. Meta-analysis of the risk of subsequent mood episodes in bipolar disorder. Psychother Psychosom. 2017;86:90-98.
5. Simhandl C, Konig B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014;75:254-263.
6. Coryell W, Turvey C, Endicott J, et al. Bipolar I affective disorder: predictors of outcome after 15 years. J Affect Disord. 1998;50:109-116.
7. Aldinger F, Schulze TG. Environmental factors, life events, and trauma in the course of bipolar disorder. Psychiatry Clin Neurosci. 2016;1–12.
8. Forty L, Ulanova A, Jones L, et al. Comorbid medical illness in bipolar disorder. Br J Psychiatry. 2014;205:465-472.
9. Sylvia LG, Shelton RC, Kemp DE, et al. Medical burden in bipolar disorder: findings from the clinical and health outcomes initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord. 2015;17:212-223.
10. Kemp DE, Sylvia LG, Calabrese JR, et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand. 2014;129:24-34.
11. Nabavi B, Mitchell AJ, Nutt D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis of 52 interview-based studies of psychiatric population. EBioMedicine. 2015;2:1405-1419.
12. Di Florio A, Craddock N, van den Bree M. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. Eur Psychiatry. 2014;29:117-124.
13. Fornaro M, Orsolini L, Marini S, et al. The prevalence and predictors of bipolar and borderline personality disorders comorbidity: systematic review and meta-analysis. J Affect Disord. 2016;195:105-118.
14. Mantere O, Isometsä E, Ketokivi M, et al. A prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders. Bipolar Disord. 2010;12:271-284.
15. Simhandl C, Radua J, König B, Amann BL. Prevalence and impact of comorbid alcohol use disorder in bipolar disorder: a prospective follow-up study. Aust N Z J Psychiatry. 2016;50:345-351.
16. Simhandl C, Radua J, König B, Amann BL. The prevalence and effect of life events in 222 bipolar I and II patients: a prospective, naturalistic 4 year follow-up study. J Affect Disord. 2015;170:166-171.
17. Kim SW, Berk L, Kulkarni J, et al. Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder. J Affect Disord. 2014;166:243-248.
18. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33.
19. Therneau T, Lumley T. Original S->R port. Survival: survival analysis including penalised likelihood [Computer program]. R package version 2.36-5. 2011. http://CRAN.R-project.org/package=survival. Accessed January 1, 2011.
20. Dell'Osso B, Holtzman JN, Goffin KC, et al. American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: more severe in multiple ways, but less severe in a few other ways. J Affect Disord. 2015;188:257-262.
21. Pavlova B, Perlis RH, Alda M, Uher R. Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2:710-717.
22. Friborg O, Martinsen EW, Martinussen M, Kaiser S, Overgård KT, Rosenvinge JH. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2014;152–154:1-11.
23. Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14:339-347.
24. Malhi GS, Tanious M, Das P, Berk M. The science and practice of lithium therapy. Aust N Z J Psychiatry. 2012;46:192-211.
25. Torrent C, Amann B, Sánchez-Moreno J, et al. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand. 2008;118:4-18.
26. Ahrens B, Müller-Oerlinghausen B, Schou M, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord. 1995;33:67-75.
27. Müller-Oerlinghausen B, Berghöfer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry. 2003;48:433-439.
28. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59:530-537.
29. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23:40-47.
30. Mcelroy SL, Kemp DE, Friedman ES, et al. Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016;133:144-153.
31. Brietzke E, Moreira CLRL, Duarte SVB, et al. Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry. 2012;53:809-812.
32. Thomsen AF, Kvist TK, Andersen PK, Kessing LV. Increased risk of developing affective disorder in patients with hypothyroidism: a register-based study. Thyroid. 2005;15:700-707.
33. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20:1101-1114.
34. Bauer M, Berman S, Stamm T, et al. Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study. Mol Psychiatry. 2016;21:229-236.
35. Maarbjerg K, Vestergaard P, Schou M. Changes in serum thyroxine (T4) and serum thyroid stimulating hormone (TSH) during prolonged lithium treatment. Acta Psychiatr Scand. 1987;75:217-221.
36. Lambert CG, Mazurie AJ, Lauve NR, et al. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort. Bipolar Disord. 2016;18:247-260.
37. Smith TJ, Hegedüs L. Graves’ Disease. N Engl J Med. 2016;375:1552–1565.
38. Whybrow PC, Prange AJJ. A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry. 1981;38:106-113.
39. Bunevicius R, Prange AJ. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry. 2010;23:363-368.
40. Stowell CP, Barnhill JW. Acute mania in the setting of severe hypothyroidism. Psychosomatics. 2005;46:259-261.
41. Lin CL, Yang SN, Shiah IS. Acute mania in a patient with hypothyroidism resulting from Hashimoto's thyroiditis. Gen Hosp Psychiatry. 2013;35.
42. Tor PC, Lee HY, Fones CSL. Late-onset mania with psychosis associated with hypothyroidism in an elderly Chinese lady. Singapore Med J. 2007;48:354-357.
43. AmdouniI F, Abid Y, Ben Khedher M, Ghachem R. Acute psychosis in the setting of severe hypothyroidism. Eur Psychiatry. 2015;30:1270.
44. Khemka D, Ali JA, Koch CA. Primary hypothyroidism associated with acute mania: case series and literature review. Exp Clin Endocrinol Diabetes. 2011;119:513-517.
45. Sathya A, Radhika R, Mahadevan S, Sriram U. Mania as a presentation of primary hypothyroidism. Singapore Med J. 2009;50.
46. Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Prim Care Companion J Clin Psychiatry. 2003;5:260-266.
47. Josephson AM, Mackenzie TB. Thyroid-induced mania in hypothyroid patients. Br J Psychiatry. 1980;137:222-228.
48. Marwaha J, Prasad KN. Hypothyroidism elicits electrophysiological noradrenergic subsensitivity in rat cerebellum. Science. 1981;214:675-677.
49. Gordon JT, Kaminski DM, Rozanov CB, Dratman MB. Evidence that 3,3’,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport. Neuroscience. 1999;93:943-954.
50. Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry. 2002;7:140-156.
51. Whybrow PC, Bauer M. Behavioral and psychiatric aspects of hypothyroidism. In: The Thyroid: A Fundamental and Clinical Text. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2005:842-863.
52. Zhang ZJ, Qiang L, Kang WH, et al. Differences in hypothyroidism between lithium-free and -treated patients with bipolar disorders. Life Sci. 2006;78:771-776.
53. Latalova K, Prasko J, Kamaradova D, Sedlackova Z, Ociskova M. Comorbidity bipolar disorder and personality disorders. Neuroendocrin Lett. 2013;34:1-8.
54. Preti A, Vrublevska J, Veroniki AA, Huedo-Medina TB, Fountoulakis KN. Prevalence, impact and treatment of generalised anxiety disorder in bipolar disorder: a systematic review and meta-analysis. Evid Based Ment Health. 2016;19:73-81.